Stedesa

US FDA accepts Sunovion's resubmitted NDA for Stedesa for review
Pharmabiz
Sun, 03/3/13 - 11:25 am
Sunovion
epilepsy
Stedesa
Dainippon Fails to Win U.S. Approval of Epilepsy Drug
Bloomberg
Tue, 05/4/10 - 10:44 am
Dainippon Sumitomo
FDA
epilepsy
Sepracor
Stedesa
Sepracor's STEDESA (Eslicarbazepine Acetate) New Drug Application Formally Accepted for Review by the FDA
Yahoo
Mon, 06/1/09 - 08:30 am
FDA
Sepracor
Stedesa
epilepsy
NDA
Sepracor Announces Submission of STEDESA() New Drug Application to FDA for Adjunctive Treatment of Epilepsy
Yahoo
Tue, 03/31/09 - 07:08 am
Sepracor
NDA
FDA
epilepsy
Stedesa